Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Copley Gets a New Life

Executive Summary

After a few volatile years, Copley Pharmaceutical has a new management team, which is gearing up the generics company for growth. Hoechst, which owns 51% of Copley, has said it wants to get out of the generics business and is letting the new management decide on an exit strategy. New CEO Daniel Korpolinski (previously head of CoCensys), believes that Copley's relationships with top national drug store chains remain strong and will help its revival.


Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts